Today I have the pleasure of interviewing George Church. I don't know how to introduce you. This is not even an exaggeration — it would honestly be easier to list out the major breakthroughs in biology over the last few decades that you haven't been involved in, from the Human Genome Project to CRISPR, age reversal to de-extinction. So you weren't exactly an easy prep. Okay, so let's start here. By what year would it be the case that, if you make it to that year, technology in bio will keep progressing to such an extent that your lifespan will increase by a year, every year, or more?
Escape velocity is sometimes what it's called for aging. Different people have estimates, and all those estimates, including mine, are going to be taken with a big grain of salt. Mainly looking at the exponentials in biotechnology and the progress that's been made in understanding — not just understanding causes of aging, but seeing real examples where you can reverse subsets of the aging phenotype — you're getting close to all of aging.
In other words, instead of just saying, 'Oh, I'm going to fix the damage in this collagen in this tendon, in this limb,' you're saying, 'Oh, I'm going to change a lot of things that are common to age-related diseases, and I'm going to get more than one at a time.'
Looking at those two phenomena — the exponentials in biotechnologies and the breakthrough in general aging, not just analysis but synthesis and therapies, and a lot of these therapies now making it into clinical trials — I wouldn't be surprised if 2050 would be a point. If we can make it to that point, 25 years… Most people listening to this have a good chance of making it 25 years. The thing is, it's not going to be some sudden point where you're going to be so sick 25 years from now that it's like hit or miss. It's more likely that you're going to be healthier 25 years from now than you thought you were going to be. There may be some, probably not some law of physics, but some economic or complexity issue that we don't know about that becomes a brick wall. I doubt it seriously, but we'll have to see.
Given the number of things you would have to solve to give us a lifespan of humpback whales…
Bowhead whales, 200 years.
Sorry, yeah. Is there any hope for doing that from somatic gene therapy alone, or would that have to be germline gene therapy?
Probably there's a lot of forces pushing it towards somatic. For one, there's 8 billion people that have missed the germline opportunity. That's to say, it doesn't apply to us, the two of us and everybody listening to this. You have to be very cautious when you say something's impossible. It's safe to say it's impossible to do it this second, but you don't know what's going to happen tomorrow, in the next decade or something. I think there's a lot that could be done. In particular, since aging is a fairly cellular phenomenon — with proteins going through the blood and other factors going through the blood, signaling and so forth — you could imagine that if you replaced every nucleus in the body, it would suddenly be young again without going all the way back to the embryo and forward again. There's various other things that are just short of that. If you replace the cells, will they fit into that niche? They might displace the old cells. That's certainly within the realm of modern synthetic biology, for cells to take over niches. I think the hardest part is the brain. Even there, even though the brain doesn't really use stem cells that much, you could artificially bring in stem cells and they could artificially fit into a circuit and learn the circuit and then displace the old ones in some way.
A Ship of Theseus kind of thing in the brain.
Yeah, exactly, Ship of Theseus, trying to maintain the connections and the memories. There's some fairly straightforward experiments that need to be done before we can really even estimate how hard that problem is. Very often there's low-hanging fruit that people just think is improbable. But it's there because biology has all these gifts where it just hands over to us levers that we can flip. Like vaccines are this amazing gift that didn't have to exist, but they do.
Is there an existing gene delivery mechanism which could deliver gene therapy to every single cell in the body?
There is nothing close to that today. But there's nothing, no law of physics, that would prevent it. Again, there's going to be practical considerations, like how many injections do you need to do to achieve that goal? But we're getting better at targeting tissues. One of my companies, Dyno Therapeutics, showed they could get a hundredfold improvement in targeting neurons in the brain, which is a big deal. That was just one little campaign that they did. That one experiment involved a lot of AI and a lot of testing of millions of different capsids. Capsids are fairly limited in the diversity and the structure that it can change to. But cells have even more possibilities. I think you could probably get delivery to everything… The question is how close to 100% do you need to get? It's going to vary from tissue to tissue. For example, for some therapies you just need to get 1% because that 1% can produce some missing enzyme. And that 1% doesn't have to necessarily be in its normal place. You can turn a muscle into part of the immune system temporarily for a vaccine. An enzyme that's normally made in, let's say the brain, you could make in the liver, if the point is just to get it into the blood. So I think that's moving along quite well.
You're one of the co-founders of Colossal, which recently announced that they de-extincted a dire wolf. Now you're working on the woolly mammoth. Do you really think we're going to bring back a woolly mammoth? The difference between an elephant and a woolly mammoth might be like a million base pairs. How do we think about the kind of thing we're actually bringing back?
People get worked up about whether we are trying to bring back, or have already, or will ever bring back a new species. If you think of it, rather than as a natural thing that we're trying to do, but as synthetic biology with goals that has potential societal… People also get worked up as to whether this could possibly benefit society in any way. Can we really fix an environment to suit humans or fix the global carbon to suit humans? The answer is we don't know. But it's worth a try, isn't it? Because it could be very cost-effective. The other aspect of it is there's a whole discipline within synthetic biology of asking, 'What's the minimum?' People often phrase it into, 'What's the maximum? What can we do?' I'm interested in both. Yes, there's millions of differences between mammoths and elephants. There are millions of differences between elephant one and elephant two, within Asian elephants and between Asians and African. But not all of those are definitive in terms of what we would normally call them and how we would normally classify them, and what their functionality would be in an ecosystem. There's this exercise that people do. We've done it, for example, with developmental biology. What's the minimum number of transcription factors it takes to make a neuron from a pluripotent stem cell? What's the minimum number of base pairs it takes to make something that will replicate to something that was done in mycoplasma originally? In a way, these are more interesting than, 'Can we make a perfect copy of something?' What's the minimum things we have to do to make it completely functional, or even functional in a particular category? How do we make it bigger? We learn the rules for how to make things bigger, how to make things replicate faster, how to use new materials, etc. With the dire wolf, we clearly didn't make an exact copy of a dire wolf. But it helped illustrate and educate people around the world on, 'What is the difference between a gray wolf and a dire wolf?' Because direwolves, they're big. Maybe they have a particular coloration. The head components tend to be bigger than the leg components. How many genes do you need to do that? Maybe this was Direwolf 2.0, and we're going to go for 3.0 and successive approximations. We might want to develop the technology for making exact copies of something, especially being able to make 100 variations on an exact copy. Because then there won't be any argument about whether you could make a dire wolf. It'll be a matter of what you should make and what would be most beneficial for the species that you're making, for the environment it lives in and for humans.
Does this teach us something interesting about phenotypes which you think are downstream from many genes, and are in fact modifiable by very few changes? Basically, could we do this to other species or to other things you might care about, like intelligence? Where you might think, there must be thousands of genes that are relevant, but there's like 20 edits you need to make, really, to be in a totally different ballgame.
You're hitting on a very interesting question. It's related to, 'What's the minimum?' For example, you almost said it. Take a very multigenic trait in humans. Height is probably the most well-studied one, simply because no matter what gene, no matter what medical condition you're studying, you collect information on height and weight and things like that. Anyway, they tracked it down to something on the order of 10,000 genes, of which we have 20,000 protein coding genes. Some of them are RNA coding genes. They each have a tiny influence on height. But if you take growth hormone, somatotropin, you have extreme examples where you'll get extremely low small stature and extremely high stature due to that one alone. In fact, it's used clinically as well for seven different medical treatments. That's a perfect example of how much we can minimize something, sometimes called reductionism. Reductionism isn't all bad. Sometimes it helps us bring a product into medicine. Sometimes it helps us understand or build a tool chest or a module that we could use in other cases and translate it to other species. You hit on it just right. Not everything will translate, but we start accumulating these widgets. It's kind of like all the electronic widgets that we accumulate over time. If you just want to slap it into the next circuit, you might be able to.
What implications does this have for gene therapy in general? What is preventing us from finding the latent knob for every single phenotype we might care about, in terms of helping with disabilities or enhancement? Is it the case that for any phenotype we care about, there will be one thing that is like HGH for height? How do we find it?
With biology we've got a real gift, which is that it's both much more complicated than almost anything we've designed from scratch, but it also is a lot more forgiving in a certain sense. You can have an animal or even a human that has two heads, which, evolutionarily, there was no selection specifically to have two heads. But just a little deviation from the normal developmental pattern during fetal development and they both function fine. They control subsets of the body and they have their own personality, their own life. There's all kinds of things you can do in biology where you're working at a very high programming level. That's a way of thinking about it. But pushing us to a new level of intelligence is going to be very challenging and maybe not even urgent. To some extent, actualizing the people that we currently have would be quite impactful, just getting them all up to whatever speed they want to be up to within the range that's been demonstrated. Some people are going to want to be like Einstein, some people won't. Some people will want to be healthy all the time. Unlikely, but some people might not. Some people might want to live to be 150, some people might want to die at 80. But if you give them that range, that capability… What if we had 8 billion super healthy, don't need to worry about food and drugs, super healthy Einstein-level intelligence, education level the best we can come up with… That would be a completely different world.
Just getting everybody to the healthy level, how much gene therapy would that take? It sounds like it wouldn't take that much, if you think that there are a couple of knobs which control very high level functions? So do you find them through the GWAS, genome wide association studies? Is it through simulations of these…
I would say mostly GWAS for humans, maybe for animals in general. For animals with synthetic biology, the smaller and the cheaper and faster replicating, the more experiments you can do. I don't want to overemphasize how single genes can do these amazing things. But there's also the possibility that multiple genes can be hypothesized and tested quickly. For example, I mentioned earlier, what's the minimum number of transcription factors it takes to turn a stem cell into a neuron? There's a bunch of recipes where you can do it with one. Maybe you want a specific neuron, you might need a few more. But then you can kind of quickly go to the answer by looking at each target cell type that exists. You can see what transcription factors does it express at the time that it's the target? Then you say, 'Let's just try those on the stem cell and see if they work.' That recipe has worked quite well. It's the basis of GC Therapeutics and a bunch of the work that we do. You can get a recipe for almost every cell type in the body. Now, that's not new cell types, but at least you've learned, to your point, about reducing the number of genes we need to manipulate in order to get to a particular goal. Here's a whole series of goals, and we can get them with 1, 2, 3, maybe 7 changed transcription factors. That's an example. There's room for lots of other examples of where you can do reduction and do not just reductionistic biology, but then constructionistic. You take it back up and make a whole complex system and see what happens. Then you can do lots of those combinations and you debug them and so forth. Some of these things you can do… In vitro things you can do probably on the order of 10^14, 10^17. Things that involve cells are typically in the billions. But this is how we're going to get inroads into the very complicated biological systems.
Can I ask you some questions about biodefense? Because some of the stuff you guys work on, or quite responsibly choose not to work on, can keep one up at night. Mirror life. Given the fact that it's physically possible, why doesn't it just happen at some point? Some day it'll get cheap enough. Somebody will care about it enough, that somebody just does it. What's the equilibrium here?
I was a co-author on a paper that warned about the dangers of mirror life. Just like I wrote a paper long ago about the dangers of having the synthetic capabilities we have for making synthetic viruses, and to some extent of having new genetic codes. They have a few things in common. The advance that we were recognizing, in our Science paper that was warning about mirror life, is not only that we had to calculate the possibility of error-prone escape or something like that was. We don't want anything to escape that we made in the lab unless there's a general societal consensus that it's a good thing. So far there aren't any examples of that. Mirror life, if it can be weaponized, that would take it to a whole other level of concern. The concern was that if we got it to a certain point, then it would be easy to weaponize it. Again, there's practical considerations that maybe that most people who consider weaponizing mirror life would probably be satisfied with weaponizing viruses that already exist, that are already pathogens. And they wouldn't want to destroy themselves and their family and their legacy and everything like that. But all it takes is one, one group probably, or one person. But your question is, is it inevitable? I don't know. It might be. It's quite possible it's already here. In other words, we already have mirror life in our solar system or maybe even on our planet. It just hasn't been weaponized. What we were saying in the Science paper is that this seems like the sort of thing that could wipe out all competing life if were properly weaponized. But there are probably a few things like that. What we really need to do is reduce the motivation to do that, maybe increase our preparedness for a variety of existential threats. Some of which will be natural, some of which will be one disgruntled person who has essentially too much power. Over the history of humanity, the amount of things that a single person can do has grown very significantly. It used to be, when you had your bare hands, there was kind of a limit to what one person could do. A large number of people could team up and get a mammoth or something like that. Today, one person with the right connections or right access to technology could blow up a city. That's a huge increase in capability. I think we want to start dialing that back a little bit somehow.
What does that look like in terms of not just mirror life, but synthetic biology in general? Maybe we're at an elevated period of the ratio to offense and defense. How do we get to an end state where — even if there's lots of people running around with bad motivations — somehow there are defenses built up that we would still survive, where we're robust against that kind of thing? Is such an equilibrium possible? Or will offense always be privileged in this game?
Offense awfully does have an advantage, but so far we haven't… We made it through the Cold War without blowing up any hydrogen bombs, as far as I know, accidentally or intentionally on enemies. We did do two atomic bombs. But a lot of that is based on the difficulty of building hydrogen or atomic bombs. The thing that's alarming to people like me is that biotechnology enables smaller and smaller efforts that are harder and harder to detect, more and more subtle to the stochastic variation between people. There's some people that are just so happy they would never want to do anything close to that. Or they're so responsible or ethical or whatever. Then there are other people who, whenever they have a bad day, they want to take a lot of people with them. Maybe some progress in psychiatric medicine would help. Again, you don't want to force that on people. You want to make sure that if they don't want to get cured, you can't force them, but you can make it available to them that might help.
Hopefully there's a more technological solution or more robust solution than that.
Well, there will be technological solutions to the psychiatric problem. It could be that even people who aren't sure whether they want to be helped or not can test, try it out, and it's reversible. They say, 'Yes, I like that better.' Okay, let's try that then. Then there's other things that cause you to have bad days. It's not just your psyche. It's also the environment. So if you're surrounded by your people being starved, infectious disease, or you're being shot at or something like that, those are things that are subject to sociological and technological solutions. If we could really solve a lot of that stuff, we could reduce the probability that one person…
This is maybe pessimistic because you're basically saying we have to solve all of society's problems before we don't have to worry about synthetic biology, which I'm not that optimistic about.
We'll solve some of them. Right? You shouldn't be. I'm not trying to reassure you. We're having a conversation about what it takes, and that might be one scenario for what it might take.
You had an interesting scheme for remapping the codons in a genome so that it's impervious to naturally evolved viruses. Is there a way in which this scheme would also work against synthetically manufactured viruses?
It's much harder. Again, the offense has the advantage. We can make a lot of different codes.
Which will limit the transmissibility?
Yeah. So one interesting thing is that there's only two chiralities. There's the current chirality and the mirror chirality. But there's maybe 10^80 different codes. Some of them you might be able to take out all at once. Anyway, coding space is a kind of more interesting space. Of course it could get even more complicated than that because the 10^83 is based on triplet codons and that sort of thing. But if they're quadruplet codons or novel alphabets and so on… We're sort of getting into a cycle of competition. It'd be better to nip it in the bud. Why did we spend so much societal resources building up to tens of thousands of nuclear warheads? Now we've dialed it back to mere thousand nuclear warheads. It's nice that we dialed it back, but why did we waste all that time and money?
Biology seems very dual-use, right? The mere fact that you, literally you, are making sequencing cheaper will just have this dual-use effect in a way that's not necessarily true for nuclear weapons. And we want that, right? We want biotechnology to advance. It's hard to pound nuclear weapons into ploughshares, as they say. I guess I am curious if there is some long-run vision where… To give another example, in cybersecurity, as time has gone on, I think our systems are more secure today than they were in the past because we found vulnerabilities and we've come up with new encryption schemes and so forth. Is there such a plausible vision in biology, or are we just stuck in a world where offense will be privileged, so we'll just have to limit access to these tools and have better monitoring, but there's not a more robust solution?
One of the things I advocated in 2004 is that we stop deluding ourselves into thinking that moratorium and voluntary signups to be good citizens is going to be sufficient. We need to also have surveillance and consequences, and mechanisms for whistleblowers to make it easy for people to report things that they think are out of line. We had essentially moratoria and disapproval for germline editing. Nevertheless, somebody did it and a lot of people knew about it. That was clearly a failure of the whole moratorium and voluntary and whistleblower components.
It worked for five years with only one defector. That's quite impressive.
Okay, half empty, half full, I'll give you that. But all it takes is one for some of these scenarios. It would have been nice if the whistleblowers could have saved him the three years in prison by getting an intervention. It's not like anybody died.
There are probably three healthy genetically-engineered children in the world now. They'll be teenagers soon. But it was a good test run that shows a failure of the system. We need to have better surveillance of all the things we don't want and consequences that are well-known.
Over the last couple of decades we've had a million-fold decrease in the cost of sequencing DNA, a thousandfold in synthesis. We have gene editing tools like CRISPR, massive parallel experiments through multiplex techniques that have come about. Of course much of this work has been led by your lab. Despite all of this, why is it the case that we don't have a huge Industrial Revolution, a huge burst of new drugs, or cures for Alzheimer's and cancer that have already come about? When you look at other trends in other fields, we have Moore's law and here's my iPhone. Why don't we have something like that in biology yet?
We have something that's about the same speed, a little bit faster than Moore's Law in biology. It's more recent, that's one aspect of it. We could stand on the shoulders of the electronics giants to go a little bit faster to catch up. I would say we do. We have the biotech industry, which has used that exponential curve to get better. It's also possible we're close to the big payoff is the other aspect, or the beginning of the big payoff. Right now we have miraculous things like cures for rare diseases. We have vaccines. We have a trillion dollars, probably, of various biotech related things if you go far enough apart. We're on the verge of really combining electronics and biology more thoroughly, and AI and biotech. It seems like we're on the same track as Moore's law, if not better.
What exactly are we on the verge of? What does 2040 look like?
Well, with 2040 we're talking about only 15 years, which is maybe two cycles of FDA approval.
2040 is post-AGI. It's a long time.
Well, I hope it's not post-AGI. I think we're rushing a little bit to get to AGI. There's lots of cool things we can do with just super AI, but we need to be very cautious with AGI. Anyway, we can get into that. I have questions for you there. We are shortening the time of getting medical products approved still in a safe way. But that's not going to completely change the exponential. It might reduce it from 10 years down to… One year is our record so far for say COVID vaccines. Maybe that'll be 10 times shorter. Maybe that will multiply out a little bit. The big thing is that all our designs will become better so there'll be fewer failures. The cost per drug will drop. There'll be things that we didn't classically consider drugs or instruments, some sort of hybrid thing. But again that won't be completely shocking. It's just going to be so much of it. There's going to be lots of diversity of solutions.
How much more are we talking about? Are we going to have 10x the amount of drugs? 100x?
I'm not even sure it's going to make sense, but 100x would not be completely surprising. Combinations of drugs will be important, using them intelligently. There'll be a lot more. Some drugs will affect everything, for example an age-related drug that could impact every disease. I'm not sure the number is going to matter so much as the quality and the impact and intersection, and software that helps physicians and regular citizens make decisions.
What specifically is changing that's enabling this? Is it just existing cost curves continuing or is it some new technique or tool that will come about?
The cost curves are affected by new tools. It's not just some automatic thing. There was a big discontinuity between Sanger sequencing and nanopores and fluorescent next-gen sequencing. Sometimes it's a merger of two things. Clearly AI merging with protein design caused a step function. These step functions get smoothed out into a smooth exponential, but there are lots of them. The next set will probably be a merger of AI with other aspects of biology, like developmental biology. After that, the merger of developmental biology with manufacturing, conquering developmental biology. In other words, it'd be actually knowing how to make any arbitrary shape given DNA as the programming material. That would be a big thing. Just having more materials in general. All the materials that we use in mechanical and electrical engineering should be made better by biotechnologies.
Well, in electronics, I wouldn't say Moore's law is stopping, but think about what we would call the 1 nanometer process, which is supposed to come out in 2027 according to the roadmap. It's not really 1 nanometer, it's more like 40 nanometers, center-to-center spacing, typically in two dimensions, maybe a little bit of three dimensions. Biology is already at 0.4 nanometer resolution and it is in three dimensions. Depending on how you count that third dimension, it could be a billion times higher density that biology is already at. We just need a little more practice with dealing with the whole periodic table. Even electrical and mechanical engineering don't typically use the whole periodic table typically, especially not at the atomic level. Biology is just really good at doing atomic precision.
So then what's the reason that over the last many decades we do have, not atomic but, close to atomic-level manufacturing with semiconductors?
40 nanometers. Right. It's quite small. It's a thousand times bigger than biology, linearly.
But the progress we have made hasn't been related to biology so far. It seems like we've made Moore's law happen. People in the 90s were saying ultimately we'd have these biomachines that are doing the computing. But it seems like we've just been using conventional manufacturing processes. What exactly is it that changes that allows us to use bio to make these things?
A few things. One is the arrival of synthetic biology. We were already kind of doing synthetic biology before, we were doing recombinant DNA, a kind of genetic engineering. It was kind of in that direction. But synthetic biology really liberated us to think a little bit bigger. Even though it started kind of focused on E. coli and yeast, it enabled us to maybe think about new amino acids, for example. If you start using the full periodic table with the amino acids, or what amino acids can catalyze, that breaks one of the major barriers. One of the major barriers between electrical and mechanical engineering and biology was the use of special materials, things that conduct electricity at the speed of light or conduct signals more generally. But there are definitely polymers that biology can make that will conduct at the speed of light. We could make a mixed neuronal system that has conventional neurons and processes that conduct at the speed of light. That would be interesting. So I think that our ability to design proteins was particularly difficult. Designing nucleic acids was great. You want two things to bind to each other? You just dial it up using Watson-Crick rules. If you want to make a three-dimensional structure, it's actually the one kind of thing where morphology is dictated by fairly simple rules. It's not how developmental biology works. We still need to figure out how that works. But DNA origami, DNA nanostructures really work. But doing it for proteins was really, really hard until maybe eight years ago, something like that. I think we're just now getting used to it. The use of chips for making DNA. You said that DNA synthesis has come down a thousandfold, it depends on who you talk to. When we came out with the first chip-based genes in a 2004 Nature paper, basically people dismissed it for about a decade. The only people that used it were collaborators and alumni. It wasn't even listed on the Moore's law curve for DNA synthesis, even though it was thousand times cheaper. It was just ignored. Now we have claims of 10^17 genes that you can make libraries of, that aren't randomized in the usual sense, where you just do error-prone PCR or spiked nucleotides. 10^17, that's a lot bigger than a thousandfold if it turns out to be practical.
Speaking of protein design, another thing you could have thought of in the 90s — people were writing about nanotechnology, Eric Drexler and so forth. Now we can go from a function that we want this tiny molecular machine to do, back to the sequence that can give it that function. Why isn't this resulting in some nanotech revolution, or will it eventually? Why didn't AlphaFold cause that?